Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Endocrinology

Pharmacology/kinetics

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study

Diabetes, Obesity and Metabolism | Apr 27, 2018 Pharmacology/kinetics

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis

JAMA | Apr 26, 2018 Pharmacology/kinetics

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: Experiences from 3-year follow-up

European Journal of Clinical Microbiology & Infectious Diseases | Apr 26, 2018 Pharmacology/kinetics

A systematic literature review and network meta-analysis comparing once-weekly semaglutide with other GLP-1 receptor agonists in patients with type 2 diabetes previously receiving 1–2 oral anti-diabetic drugs

Diabetes Therapy | Evidence based | Apr 26, 2018 Pharmacology/kinetics

Effect of metformin use on the risk and prognosis of endometrial cancer: A systematic review and meta-analysis

BMC Cancer | Apr 25, 2018 Pharmacology/kinetics

Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease

Diabetes, Obesity and Metabolism | Apr 24, 2018 Pharmacology/kinetics

Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trials

Diabetes, Obesity and Metabolism | Apr 24, 2018 Pharmacology/kinetics

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors vs other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

Diabetes, Obesity and Metabolism | Apr 23, 2018 Pharmacology/kinetics

SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis

Diabetes, Obesity and Metabolism | Apr 20, 2018 Pharmacology/kinetics

Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes

Bone | Apr 19, 2018 Pharmacology/kinetics

« Prev 1 … 97 98 99 100 101 … 122 Next »

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: Experiences from 3-year follow-up

A systematic literature review and network meta-analysis comparing once-weekly semaglutide with other GLP-1 receptor agonists in patients with type 2 diabetes previously receiving 1–2 oral anti-diabetic drugs

Effect of metformin use on the risk and prognosis of endometrial cancer: A systematic review and meta-analysis

Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease

Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trials

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors vs other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis

Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: A systematic review and meta-analysis

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: Experiences from 3-year follow-up

A systematic literature review and network meta-analysis comparing once-weekly semaglutide with other GLP-1 receptor agonists in patients with type 2 diabetes previously receiving 1–2 oral anti-diabetic drugs

Effect of metformin use on the risk and prognosis of endometrial cancer: A systematic review and meta-analysis

Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease

Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trials

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors vs other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis

Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic